Penn Capital Management Company, LLC
Position in TGTX — Tg Therapeutics, Inc.
CIK 1158202
PHILADELPHIA, PA
Position in TGTX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$29,451,520
+$11,447,609 QoQ
Shares Held
536,067
-1.1% QoQ
Ownership
0.350%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
#34
of 425 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Penn Capital Management Company, LLC holds $100,162,194 across 7 Biotechnology names. TGTX ranks #3 (29.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
298,914 | $34,993,861 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
100,337 | $31,715,522 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
This page
|
536,067 | $29,451,520 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,811 | $1,509,366 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
14,968 | $850,332 | |
| 6 | PVLA |
Palvella Therapeutics, Inc.
|
5,506 | $841,426 | |
| 7 | NRIX |
Nurix Therapeutics, Inc.
|
32,983 | $800,167 |
All Filings in TGTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,451,520 | 536,067 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $18,003,911 | 541,960 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $16,041,267 | 538,117 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $18,830,517 | 521,260 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $15,956,706 | 443,365 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,463,736 | 392,182 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,577,380 | 351,408 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||